Abstract:Importance: The clinical value of current multifactorial algorithms for individualized assessment of dementia risk remains unclear. Objective: To evaluate the clinical value associated with 4 widely used dementia risk scores in estimating 10-year dementia risk. Design, setting, and participants: This prospective population-based UK Biobank cohort study assessed 4 dementia risk scores at baseline (2006-2010) and ascertained incident dementia during the following 10 years. Replication with a 20-year follow-up was based on the British Whitehall II study. For both analyses, participants who had no dementia at baseline, had complete data on at least 1 dementia risk score, and were linked to electronic health records from hospitalizations or mortality were included. Data analysis was conducted from July 5, 2022, to April 20, 2023. Exposures: Four existing dementia risk scores: the Cardiovascular Risk Factors, Aging and Dementia (CAIDE)-Clinical score, the CAIDE-APOE-supplemented score, the Brief Dementia Screening Indicator (BDSI), and the Australian National University Alzheimer Disease Risk Index (ANU-ADRI). Main outcomes and measures: Dementia was ascertained from linked electronic health records. To evaluate how well each score predicted the 10-year risk of dementia, concordance (C) statistics, detection rate, false-positive rate, and the ratio of true to false positives were calculated for each risk score and for a model including age alone. Results: Of 465 929 UK Biobank participants without dementia at baseline (mean [SD] age, 56.5 [8.1] years; range, 38-73 years; 252 778 [54.3%] female participants), 3421 were diagnosed with dementia at follow-up (7.5 per 10 000 person-years). If the threshold for a positive test result was calibrated to achieve a 5% false-positive rate, all 4 risk scores detected 9% to 16% of incident dementia and therefore missed 84% to 91% (failure rate). The corresponding failure rate was 84% for a model that included age only. For a positive test result calibrated to detect at least half of future incident dementia, the ratio of true to false positives ranged between 1 to 66 (for CAIDE-APOE-supplemented) and 1 to 116 (for ANU-ADRI). For age alone, the ratio was 1 to 43. The C statistic was 0.66 (95% CI, 0.65-0.67) for the CAIDE clinical version, 0.73 (95% CI, 0.72-0.73) for the CAIDE-APOE-supplemented, 0.68 (95% CI, 0.67-0.69) for BDSI, 0.59 (95% CI, 0.58-0.60) for ANU-ADRI, and 0.79 (95% CI, 0.79-0.80) for age alone. Similar C statistics were seen for 20-year dementia risk in the Whitehall II study cohort, which included 4865 participants (mean [SD] age, 54.9 [5.9] years; 1342 [27.6%] female participants). In a subgroup analysis of same-aged participants aged 65 (±1) years, discriminatory capacity of risk scores was low (C statistics between 0.52 and 0.60). Conclusions and relevance: In these cohort studies, individualized assessments of dementia risk using existing risk prediction scores had high error rates. These findings suggest that the scores were of limited value in targeting people for dementia prevention. Further research is needed to develop more accurate algorithms for estimation of dementia risk.

Development of a Novel Dementia Risk Prediction Model in the General Population: A Large, Longitudinal, Population-Based Machine-Learning Study

Development and Validation of a Dementia Risk Prediction Model in the General Population: An Analysis of Three Longitudinal Studies

Dementia prediction in the general population using clinically accessible variables: a proof-of-concept study using machine learning. The AGES-Reykjavik study

Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study

Develop a Diagnostic Tool for Dementia Using Machine Learning and Non-Imaging Features

External validation of dementia prediction models in Black or African American and White older adults: A longitudinal population‐based study in the United States

Incremental Value of Multidomain Risk Factors for Dementia Prediction: A Machine Learning Approach

Predictors of Dementia in the Oldest Old: A Novel Machine Learning Approach

Alzheimer’s disease risk prediction using automated machine learning

Early Prediction of Alzheimer's Disease and Related Dementias Using Real-World Electronic Health Records.

Predicting Alzheimer's Disease with Interpretable Machine Learning.

Development and validation of a patient-level model to predict dementia across a network of observational databases

Developing a Novel Holistic, Personalized Dementia Risk Prediction Model via Integration of Machine Learning and Network Systems Biology Approaches

Data-driven discovery of probable Alzheimer's disease and related dementia subphenotypes using electronic health records

Developing an Explainable Machine Learning-Based Personalised Dementia Risk Prediction Model: A Transfer Learning Approach With Ensemble Learning Algorithms

What's New in Dementia Risk Prediction Modelling? An Updated Systematic Review

Predicting Alzheimer's disease from cognitive footprints in mid and late life: How much can register data and machine learning help?

Estimating Dementia Risk Using Multifactorial Prediction Models

Modified Dementia Risk Score As a Tool for the Prediction of Dementia: a Prospective Cohort Study of 239745 Participants

Predicting Alzheimer’s Disease from Cognitive Footprints in Mid and Late Life: How Much Can Register Data and Machine Learning Help?

Machine learning prediction of incidence of Alzheimer’s disease using large-scale administrative health data